Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Category Archives: Ulcerative Colitis
Palisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s … – GlobeNewswire
Posted: Published on April 12th, 2024
PALI-2108 in development for the treatment of moderate-to-severe ulcerative colitis (UC) advancing towards Phase 1 clinical study before year end Carlsbad,CA, April 10, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc.(Nasdaq: PALI) (Palisade, Palisade Bio or the Company), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that it presented at IBD Innovate: Product Development for Crohns & Colitis held April 9-10, 2024 in Cambridge, MA. Continue reading
Posted in Ulcerative Colitis
Comments Off on Palisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s … – GlobeNewswire
What is ulcerative colitis? Louise Thompson reveals she has stoma bag – Yahoo Lifestyle UK
Posted: Published on April 12th, 2024
Louise Thompson has revealed she has a stoma bag to help manage her ulcerative colitis. (Getty Images) Former Made in Chelsea star Louise Thompson has revealed that she has had a stoma bag fitted Continue reading
Posted in Ulcerative Colitis
Comments Off on What is ulcerative colitis? Louise Thompson reveals she has stoma bag – Yahoo Lifestyle UK
Living with IBD: What coping strategies are most effective? – News-Medical.Net
Posted: Published on March 15th, 2024
In a recent review article published in the Journal of Clinical Medicine, researchers summarized the results of a systematic review that explored the impact of different coping strategies for people living with inflammatory bowel disease (IBD). Study:Coping Strategies and Inflammatory Bowel Disease: A Narrative Review. Continue reading
Posted in Ulcerative Colitis
Comments Off on Living with IBD: What coping strategies are most effective? – News-Medical.Net
Etrasimod approved to treat patients over the age of 16 with ulcerative colitis – GOV.UK
Posted: Published on March 15th, 2024
Ulcerative colitis is a long-term condition where the colonand rectum become inflamed. Smallulcers can develop onthe colons liningand can bleed and produce pus. The main symptoms of ulcerative colitis are recurring diarrhoea, which may contain blood, mucus or pus, stomach pain and increased stool frequency Continue reading
Posted in Ulcerative Colitis
Comments Off on Etrasimod approved to treat patients over the age of 16 with ulcerative colitis – GOV.UK
Clinical outcomes of patients with remitting ulcerative colitis after discontinuation of indigo naturalis | Scientific Reports – Nature.com
Posted: Published on March 15th, 2024
Study design and patient population A single-center retrospective study design was used to investigate the follow-up of patients treated with IN between 2015 and 2020. Powdered IN (Fujian Province, China) was purchased from Uchidawakanyaku Ltd. (Tokyo, Japan) Continue reading
Posted in Ulcerative Colitis
Comments Off on Clinical outcomes of patients with remitting ulcerative colitis after discontinuation of indigo naturalis | Scientific Reports – Nature.com
Pfizers Velsipity receives MHRA and NICE authorisations to treat ulcerative colitis – PMLiVE
Posted: Published on March 15th, 2024
Pfizers once-daily S1P receptor modulator Velsipity (etrasimod) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat moderately-to-severely active ulcerative colitis (UC). The drug has been concurrently recommended by the National Institute for Health and Care Excellence (NICE) for use in patients aged 16 years and older who have had an inadequate response, lost response or been intolerant to conventional therapy or biological treatment. Affecting approximately 300,000 people in the UK, UC is a chronic, immune-mediated condition where the colon and rectum become inflamed, causing symptoms such as frequent diarrhoea, bowel urgency, rectal bleeding, abdominal pain, fatigue, fever and anaemia. Continue reading
Posted in Ulcerative Colitis
Comments Off on Pfizers Velsipity receives MHRA and NICE authorisations to treat ulcerative colitis – PMLiVE
Anti-integrin v6 autoantibodies are a potential biomarker for ulcerative colitis-like immune checkpoint inhibitor … – Nature.com
Posted: Published on March 15th, 2024
Patients This was a retrospective study targeting patients with ICI-induced colitis who had undergone colonoscopy at the onset of the disease at Kyoto University Hospital, affiliated hospitals, and Kindai University Faculty of Medicine between April 2018 and April 2023. All but one patient (Case 1) was treated with only ICI treatment. ICI-induced colitis was defined as diarrhea or bloody stools following ICI administration and/or with histological evaluation [5]. Continue reading
Posted in Ulcerative Colitis
Comments Off on Anti-integrin v6 autoantibodies are a potential biomarker for ulcerative colitis-like immune checkpoint inhibitor … – Nature.com
Etrasimod (Velsipity) recommended as a treatment option for Ulcerative Colitis in England – Crohn’s & Colitis UK
Posted: Published on March 15th, 2024
NICE is the organisation that decides whether treatments should be available on the NHS in England. Wales and Northern Ireland usually follow NICE decisions too. In Scotland, these decisions are made by the Scottish Medicines Consortium (SMC). Continue reading
Posted in Ulcerative Colitis
Comments Off on Etrasimod (Velsipity) recommended as a treatment option for Ulcerative Colitis in England – Crohn’s & Colitis UK
I’m a Frequent Traveler With Crohn’s DiseaseHere Are My Packing List Non-Negotiables – Cond Nast Traveler
Posted: Published on March 15th, 2024
When I was a kid, I took lots of tripsto the bathroom. Continue reading
Posted in Ulcerative Colitis
Comments Off on I’m a Frequent Traveler With Crohn’s DiseaseHere Are My Packing List Non-Negotiables – Cond Nast Traveler
Pfizer’s Velsipity heading for NHS use in ulcerative colitis – pharmaphorum
Posted: Published on March 15th, 2024
Up to 25,000 people with ulcerative colitis (UC) in England could be in line for treatment with Pfizers once-daily oral therapy Velsipity, after NICE recommended its use by the NHS. The new guidance emerged on the same day that Velsipity (etrasimod) was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as a treatment for moderately to severely active UC, a few weeks after it was cleared by the European Commission. Continue reading
Posted in Ulcerative Colitis
Comments Off on Pfizer’s Velsipity heading for NHS use in ulcerative colitis – pharmaphorum